부가기능
BRIEF COMMUNICATION - Treatment of Complicated Sarcoidosis with Infliximab Anti-Tumor Necrosis Factor-a Therapy - Infliximab therapy was successful in a patient with sarcoidosis. Tumor necrosis factor-a may be an important mediator of clinical disease in sarcoidosis and could be an attractive target for therapeutic intervention. However, infliximab may cause adverse effects associated with cytokine cascade manipulation./
기사 상세정보
서평
서평등록 중 오류가 발생하였습니다. 재시도 하십시오.